A new bioinformatics approach identifies overexpression of GRB2 as a poor prognostic biomarker for prostate cancer.
Iwata T, Sedukhina AS, Kubota M, Oonuma S, Maeda I, Yoshiike M, Usuba W, Minagawa K, Hames E, Meguro R, Cho S, Chien SHH, Urabe S, Pae S, Palanisamy K, Kumai T, Yudo K, Kikuchi E, Sato K.
Iwata T, et al. Among authors: yudo k.
Sci Rep. 2021 Mar 11;11(1):5696. doi: 10.1038/s41598-021-85086-9.
Sci Rep. 2021.
PMID: 33707553
Free PMC article.